U.S. Procalcitonin, IL-6, And IL-10 Tests Market Projected To Raise At USD 300.95 Million By 2030
San Francisco, 6 Sep 2024: The Report U.S. Procalcitonin, IL-6, And IL-10 Tests Market Size, Share & Trends Analysis Report By Patient Type (Inpatient, Outpatient), By Type (Procalcitonin, IL-6, IL-10), By End Use, By Application, By Payer Type, By State, And Segment Forecasts, 2024 - 2030 The U.S. procalcitonin, IL-6, and IL-10 tests market size is anticipated to reach USD 300.5 million by 2030 and is anticipated to expand at a CAGR of 4.37% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing cases of sepsis and bacterial infections in the U.S. are significant drivers of the demand for these biomarker tests. These tests are crucial for the early detection and management of infections, thereby driving the market growth. Furthermore, innovations and improvements in testing technologies, including automation and high-throughput systems, have made these tests more accessible and reliable, leading to an increase in their usage. PCT testing has